Rahul Nayak

New analysis: The 10 drug prices Medicare is likely to negotiate first 💉Insulin + diabetes meds 💊 Cancer drugs 🩸Blood thinners Used by 8 million ppl & account for nearly 1/5 of Part D spend From me @sanjaykishore31 @RahulKNayak in @Health_Affairs 🧵 healthaffairs.org/content/forefr…

@Health_Affairs @RahulKNayak @BrighamWomens @WinshipAtEmory twitter.com/MicahJohnsonMD…

Our findings also underscore the potential role of soft policies, such as university and academic licensing practices, in global public health. These policies have been advocated for by groups such as @uaem 13/13

Third, for inventions owned by taxpayers, the federal government could ensure (through legislation or regulation) that these drugs are available to patients/payors at reasonable prices. Though there seems little appetite among lawmakers to do so... 12/13

New paper in @JAMAInternalMed by @PORTAL_Research with @charliecwlee, Jerry Avorn & @akesselheim on public sector contributions to new biologic drugs. jamanetwork.com/journals/jamai… 1/13

Thanks @DataProgress @BeaHero for putting out our call for massive investments in community health centers. In the wake of COVID, it's time to guarantee access to primary care for all. CC: @MicahJohnsonMD

Today’s the day! MEDICARE FOR ALL: A CITIZEN’S GUIDE is available from your local bookstore or at medicareforallbook.com (Photo: @PenguinBookshop)

Completely agree, @peterbachmd! $3120 per course seems like a lot of $$ to pay drug that doesn't save lives @gregggonsalves @jbkrell @PrEP4AllNow @akapczynski @ADPaltiel @RobbieForChange @GileadSciences

Congratulations to now Dr. Rebecca Kahn @rebeccajk13 who last week completed her PhD at @CCDD_HSPH @HarvardChanSPH @HarvardEpi! Wonderful talk by a wonderful person and collaborator.

🗣 BLACK LIVES MATTER